Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Fact checked by Nick Blackmer Crohn's disease can cause symptoms unrelated to your digestion. Health's Crohn's Disease ...
In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...
An ustekinumab biosimilar to Stelara launched in France, completing its rollout across 5 major European markets and paving ...
With the spread of illnesses like norovirus and increasing mental health concerns, St. Liam Hall has become a critical hub ...
Home Bladder Cancer Test: New Urine-Based Kit May Enable Early DiagnosisThe research team has developed a urine-based ...
The NHS doesn’t offer bowel screening until we’re 50. Yet with cancer rates rising, it may be worth forking out for a private ...
Eli Lilly and Company (NYSE:LLY), a leading global pharmaceutical firm, finds itself at a pivotal juncture as it navigates a ...
Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback